Header Logo

Connection

Sarah Hughes to Drug Hypersensitivity

This is a "connection" page, showing publications Sarah Hughes has written about Drug Hypersensitivity.
Connection Strength

0.363
  1. Hughes S, Hughes A, Brothers C, Spreen W, Thorborn D. PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events. Pharm Stat. 2008 Apr-Jun; 7(2):121-9.
    View in: PubMed
    Score: 0.291
  2. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, J?gel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008 Feb 07; 358(6):568-79.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.